The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Central Nervous System Drugs-Global Market Insights and Sales Trends 2025

Central Nervous System Drugs-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1838569

No of Pages : 101

Ask Your Query
Synopsis
The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease.
The global Central Nervous System Drugs market size is expected to reach US$ 186780 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The market is mainly driven by the significant applications of Central Nervous System Drugs in various end use industries. The expanding demands from the Hospital and Retail Pharmacy, are propelling Central Nervous System Drugs market. OTC, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rx Drugs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Central Nervous System Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Central Nervous System Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Central Nervous System Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Central Nervous System Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Central Nervous System Drugs covered in this report include Biogen, Pfizer, Teva, Novartis, Johnson & Johnson, EliLilly, Otsuka, Merck and AstraZeneca, etc.
The global Central Nervous System Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biogen
Pfizer
Teva
Novartis
Johnson & Johnson
EliLilly
Otsuka
Merck
AstraZeneca
Novartis
Takeda
Global Central Nervous System Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Central Nervous System Drugs market, Segment by Type:
OTC
Rx Drugs
Global Central Nervous System Drugs market, by Application
Hospital
Retail Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Central Nervous System Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Central Nervous System Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Central Nervous System Drugs Market Overview
1.1 Central Nervous System Drugs Product Overview
1.2 Central Nervous System Drugs Market Segment by Type
1.2.1 OTC
1.2.2 Rx Drugs
1.3 Global Central Nervous System Drugs Market Size by Type
1.3.1 Global Central Nervous System Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Central Nervous System Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Central Nervous System Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Central Nervous System Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Central Nervous System Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Central Nervous System Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Central Nervous System Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Central Nervous System Drugs Sales Breakdown by Type (2018-2023)
2 Global Central Nervous System Drugs Market Competition by Company
2.1 Global Top Players by Central Nervous System Drugs Sales (2018-2023)
2.2 Global Top Players by Central Nervous System Drugs Revenue (2018-2023)
2.3 Global Top Players by Central Nervous System Drugs Price (2018-2023)
2.4 Global Top Manufacturers Central Nervous System Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Central Nervous System Drugs Market Competitive Situation and Trends
2.5.1 Central Nervous System Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Central Nervous System Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Central Nervous System Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Central Nervous System Drugs Market
2.8 Key Manufacturers Central Nervous System Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Central Nervous System Drugs Status and Outlook by Region
3.1 Global Central Nervous System Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Central Nervous System Drugs Historic Market Size by Region
3.2.1 Global Central Nervous System Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Central Nervous System Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Central Nervous System Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Central Nervous System Drugs Forecasted Market Size by Region
3.3.1 Global Central Nervous System Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Central Nervous System Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Central Nervous System Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Central Nervous System Drugs by Application
4.1 Central Nervous System Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Retail Pharmacy
4.2 Global Central Nervous System Drugs Market Size by Application
4.2.1 Global Central Nervous System Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Central Nervous System Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Central Nervous System Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Central Nervous System Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Central Nervous System Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Central Nervous System Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Central Nervous System Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Central Nervous System Drugs Sales Breakdown by Application (2018-2023)
5 North America Central Nervous System Drugs by Country
5.1 North America Central Nervous System Drugs Historic Market Size by Country
5.1.1 North America Central Nervous System Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Central Nervous System Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Central Nervous System Drugs Sales in Value by Country (2018-2023)
5.2 North America Central Nervous System Drugs Forecasted Market Size by Country
5.2.1 North America Central Nervous System Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Central Nervous System Drugs Sales in Value by Country (2024-2029)
6 Europe Central Nervous System Drugs by Country
6.1 Europe Central Nervous System Drugs Historic Market Size by Country
6.1.1 Europe Central Nervous System Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Central Nervous System Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Central Nervous System Drugs Sales in Value by Country (2018-2023)
6.2 Europe Central Nervous System Drugs Forecasted Market Size by Country
6.2.1 Europe Central Nervous System Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Central Nervous System Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Central Nervous System Drugs by Region
7.1 Asia-Pacific Central Nervous System Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Central Nervous System Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Central Nervous System Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Central Nervous System Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Central Nervous System Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Central Nervous System Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Central Nervous System Drugs Sales in Value by Region (2024-2029)
8 Latin America Central Nervous System Drugs by Country
8.1 Latin America Central Nervous System Drugs Historic Market Size by Country
8.1.1 Latin America Central Nervous System Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Central Nervous System Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Central Nervous System Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Central Nervous System Drugs Forecasted Market Size by Country
8.2.1 Latin America Central Nervous System Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Central Nervous System Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Central Nervous System Drugs by Country
9.1 Middle East and Africa Central Nervous System Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Central Nervous System Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Central Nervous System Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Central Nervous System Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Central Nervous System Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Central Nervous System Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Central Nervous System Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Biogen
10.1.1 Biogen Company Information
10.1.2 Biogen Introduction and Business Overview
10.1.3 Biogen Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Biogen Central Nervous System Drugs Products Offered
10.1.5 Biogen Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Central Nervous System Drugs Products Offered
10.2.5 Pfizer Recent Development
10.3 Teva
10.3.1 Teva Company Information
10.3.2 Teva Introduction and Business Overview
10.3.3 Teva Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Teva Central Nervous System Drugs Products Offered
10.3.5 Teva Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis Central Nervous System Drugs Products Offered
10.4.5 Novartis Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Information
10.5.2 Johnson & Johnson Introduction and Business Overview
10.5.3 Johnson & Johnson Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Johnson & Johnson Central Nervous System Drugs Products Offered
10.5.5 Johnson & Johnson Recent Development
10.6 EliLilly
10.6.1 EliLilly Company Information
10.6.2 EliLilly Introduction and Business Overview
10.6.3 EliLilly Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 EliLilly Central Nervous System Drugs Products Offered
10.6.5 EliLilly Recent Development
10.7 Otsuka
10.7.1 Otsuka Company Information
10.7.2 Otsuka Introduction and Business Overview
10.7.3 Otsuka Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Otsuka Central Nervous System Drugs Products Offered
10.7.5 Otsuka Recent Development
10.8 Merck
10.8.1 Merck Company Information
10.8.2 Merck Introduction and Business Overview
10.8.3 Merck Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Merck Central Nervous System Drugs Products Offered
10.8.5 Merck Recent Development
10.9 AstraZeneca
10.9.1 AstraZeneca Company Information
10.9.2 AstraZeneca Introduction and Business Overview
10.9.3 AstraZeneca Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 AstraZeneca Central Nervous System Drugs Products Offered
10.9.5 AstraZeneca Recent Development
10.10 Novartis
10.10.1 Novartis Company Information
10.10.2 Novartis Introduction and Business Overview
10.10.3 Novartis Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Novartis Central Nervous System Drugs Products Offered
10.10.5 Novartis Recent Development
10.11 Takeda
10.11.1 Takeda Company Information
10.11.2 Takeda Introduction and Business Overview
10.11.3 Takeda Central Nervous System Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Takeda Central Nervous System Drugs Products Offered
10.11.5 Takeda Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Central Nervous System Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Central Nervous System Drugs Industrial Chain Analysis
11.4 Central Nervous System Drugs Market Dynamics
11.4.1 Central Nervous System Drugs Industry Trends
11.4.2 Central Nervous System Drugs Market Drivers
11.4.3 Central Nervous System Drugs Market Challenges
11.4.4 Central Nervous System Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Central Nervous System Drugs Distributors
12.3 Central Nervous System Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock